For: | Zhu JJ, Wilding JPH, Gu XS. Combining GLP-1 receptor agonists and SGLT-2 inhibitors for cardiovascular disease prevention in type 2 diabetes: A systematic review with multiple network meta-regressions. World J Diabetes 2024; 15(10): 2135-2146 [PMID: 39493569 DOI: 10.4239/wjd.v15.i10.2135] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i10/2135.htm |
Number | Citing Articles |
1 |
Vanishri Ganakumar, Cornelius J Fernandez, Joseph M Pappachan. Antidiabetic combination therapy and cardiovascular outcomes: An evidence-based approach. World Journal of Diabetes 2025; 16(4): 102390 doi: 10.4239/wjd.v16.i4.102390
|
2 |
Juan J. Gorgojo-Martínez. Adipocentric Strategy for the Treatment of Type 2 Diabetes Mellitus. Journal of Clinical Medicine 2025; 14(3): 678 doi: 10.3390/jcm14030678
|